Second Generation FIT® is the revolutionary test to aid in the detection of Colorectal Cancer that is fast, accurate, and easy to use. Now you can test for the same advanced colon cancer biomarker that hospitals, labs, and physicians offices in the United States and Europe do in the privacy of your own home, with no diet or medicine restrictions.
Second Generation FIT® is amazingly accurate, detecting globlin levels at 50 ng/mL (50 billionths of a gram). The American College of Gastroenterology recommends a FIT test once per year, and recognizes the Fecal Immunochemical Test as the number one alternative to colonoscopy.³ In fact,in a recent study of over 26,000 patients, FIT caught more colon cancers than colonoscopy did.⁴ Continue reading below to see what peer reviewed journals, gastroenterologists, and publications say about Second Generation FIT®.
Their test has been the bestselling colon cancer screening test in the United States for 6 consecutive years. Pro's of the Second Generation FIT® test include it's OTC designation with the US Food and Drug Administration, it's affordability compared with similar products, ease of use, easy to find, and the fastest results.
The company was founded in 2011 and started producing consumer tests in 2016. The FIT test can be ordered over-the-counter for use in testing for blood in the stool. Pinnacle BioLabs indicates that its test detects globlin (proteins found in blood) levels at 50 ng/mL (50 billionths of a gram) with 98% sensitivity and 96% specificity.